South Africa "May Control Drug Prices"

25 September 1994

South Africa's department of Health could reintroduce price controls to curb the soaring costs of medicines, Health Minister Nkosazana Zuma has warned in Parliament. Discussing the high costs of medicines, she said that "drastic steps" are necessary; drugs are the fastest-growing and single-largest item of spending for medical schemes.

A committee has been set up to develop a Departmental pharmaceutical policy, Dr Zuma announced. Its brief includes developing a general pricing plan for medicines in the private and public sector, an essential medicines list for the public sector, which serves 80% of the population, and strategies to increase the use of generics and improve medicine distribution in rural areas (Marketletter September 12).

The committee will also consider the reintroduction of price controls, and investigate the mark-up system, which the Minister believes is an incentive to the use of more expensive drugs. A previous investigation had recommended that pharmacists and dispensing doctors should be remunerated by dispensing fees and not by the mark-up system.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight